ADHD Medication Shortage in 2026: What Patients Need to Know

Millions of Americans with ADHD face ongoing difficulties filling their prescriptions. The medication shortage that began in October 2022 continues into 2026. Understanding the current landscape helps patients plan ahead and manage costs.

Which Medications Are Still in Shortage

Source: Pexels

The FDA Drug Shortage Database lists multiple ADHD stimulants as currently unavailable. Generic amphetamine mixed salts, including both immediate-release and extended-release forms, remain in shortage. Methylphenidate has been on the FDA shortage list continuously since July 2023. Brand-name drugs like Adderall and Vyvanse have fluctuated between available and scarce.

Why the Shortage Persists

Source: Pexels

ADHD medication prescriptions grew 60% between 2012 and 2023, according to a DEA-commissioned report. The DEA sets annual production quotas for Schedule II controlled substances, limiting how much manufacturers can produce. Even when demand rises, manufacturers cannot exceed their allotted quota. Supply chain disruptions and raw ingredient delays have further strained production.

Impact on Patients and Costs

Source: Pexels

An AJMC study found that 71.5% of adults with ADHD had difficulty filling their prescriptions due to unavailability. The estimated prescription fill rate for amphetamine medications dropped 11% from 2022 to 2023. Patients often call multiple pharmacies each month searching for available stock. When preferred generics are unavailable, patients may pay significantly more for alternative brands.

DEA Quota Increases in 2026

Source: Pexels

The DEA released its 2026 aggregate production quotas in January 2026, increasing limits for key ADHD medications. The Vyvanse production quota rose approximately 24% in late 2025. Despite these increases, experts note that supply has not yet fully caught up with demand. The CDC issued Health Alert Network advisory HAN-00510, warning that disrupted access to stimulants increases risk of injury.

What Patients Can Do Now

Talk to your prescriber about therapeutic alternatives if your usual medication is unavailable. Check the FDA Drug Shortage Database for real-time availability updates. Use GoodRx or similar tools to compare pharmacy prices and stock in your area. Ask your doctor about non-stimulant options like Strattera or Wellbutrin as temporary alternatives.

---

Data cited from the FDA Drug Shortage Database, DEA 2026 Aggregate Production Quotas, AJMC (American Journal of Managed Care), and CDC Health Alert Network. This article is for informational purposes only and does not constitute medical advice.